Arcellx, Inc. ACLX
CIK 0001786205
Form 4 transactions dated Nov 1, 2023 to Nov 7, 2026, as reported to the SEC.
Insider purchases & sales
- Purchased
- $0.00
- Sold
- $130.82M
Nov 1, 2023 – Apr 28, 2026
Available records · partial months are marked ·
| Date | Insider | Activity | Trade value (USD) | % of prior holding | |
|---|---|---|---|---|---|
| Nov 17, 2025 | Heery Christopher CHIEF MEDICAL OFFICER | Sale10b5-1 footnote | $30.60K 340 shares sold | 54.49% sold Direct holding | ▾ |
| Oct 15, 2025 | Gilson Michelle CHIEF FINANCIAL OFFICER | Sale10b5-1 footnote | $488.32K 5,364 shares sold | 38.79% sold Direct holding | ▾ |
| Oct 6, 2025 | Gilson Michelle CHIEF FINANCIAL OFFICER | Sale10b5-1 footnote | $91.73K 1,064 shares sold | 7.14% sold Direct holding | ▾ |
| Oct 3, 2025 | Gilson Michelle CHIEF FINANCIAL OFFICER | Sale10b5-1 footnote | $419.87K 4,882 shares sold | 24.69% sold Direct holding | ▾ |
| Sep 30, 2025 | Heery Christopher CHIEF MEDICAL OFFICER | Sale10b5-1 footnote | $1.71M 21,034 shares sold | 97.12% sold Direct holding | ▾ |
| Sep 29, 2025 | Heery Christopher CHIEF MEDICAL OFFICER | Sale10b5-1 footnote | $5.85K 73 shares sold | 0.34% sold Direct holding | ▾ |
| Sep 26, 2025 | Heery Christopher CHIEF MEDICAL OFFICER | Sale10b5-1 footnote | $993.16K 12,396 shares sold | 36.32% sold Direct holding | ▾ |
| Sep 19, 2025 | Heery Christopher CHIEF MEDICAL OFFICER | Sale10b5-1 footnote | $24.00K 300 shares sold | 0.87% sold Direct holding | ▾ |
| Sep 18, 2025 | Heery Christopher CHIEF MEDICAL OFFICER | Sale10b5-1 footnote | $267.47K 3,343 shares sold | 8.85% sold Direct holding | ▾ |
| Jun 10, 2025 | Patel Kavita Director | Sale10b5-1 footnote | $101.04K 1,500 shares sold | 100.00% sold Direct holding | ▾ |
Showing 30 / 34 record groups in 2025. The complete set is available through the API.
Follow the people behind the trades.
Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
+ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 30 of 34 purchase / sale groups and 30 of 56 other groups; the totals and the monthly series cover the whole window.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.
MCP https://api.akkrudata.ai/mcp
akkru_insider_transactions
{"action":"list","ticker":"ACLX","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP / CLI documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.